Skip to main content
Contact Us
Subscriber Sign In
navigation
サイト内検索
What We Do
Commercial Intelligence
Products
Evaluate Pharma
Evaluate Omnium
Evaluate Medtech
Evaluate Epi
Japan Drug Forecasts
Europe Drug Forecasts
Pharma Consulting & Analytics
Pharma Consulting & Analytics
Data Feeds
Evaluate Vantage
News
Analysis
Policy & Pricing
Insights
Events
Medtech
Therapy Areas
Evaluate for Biotech
How We Can Help You
Pharma and Biotech
Financial Services
Management Consultancies
Service Providers
Customer Testimonials
Thought Leadership
Multimedia
Blog
About Us
Press Releases
Media Coverage
Executive Team
Vision & History
Contact Us
Sign Up for Evaluate Vantage
Talent
Subscriber Sign In
Search
Open configuration options
Search
Vantage
News
Snippets
Deals
Trial results
Patents and litigation
Corporate strategy
Analysis
Interviews
Spotlight
Vantage points
Vantage views
Insights
M&A
IPO
NME approvals
Quarterly shareprice performance
Venture financing
Vantage data points
Other data
Events
Company events
Conferences
Upcoming events
Medtech
Therapy Areas
Breadcrumb
Home
Vantage
Pharmaceutical Companies
Tigenix
Evaluate
January 05, 2018
Snippet roundup: Spark sets record price tag and Biontech brings in big bucks
December 18, 2017
Tigenix draws closer to European nod
September 27, 2017
Therapy focus – mostly pain and little gain for osteoarthritis research
December 14, 2016
After US approval, Vericel’s headache begins
November 11, 2015
A pyrrhic victory for Ocata investors
August 24, 2015
TiGenix plugs gap with EU data
October 02, 2013
US outperformance dominates small-cap drug stock gains
March 02, 2011
EP Vantage Interview - TiGenix expands into stem cell space
January 07, 2011
Comeback stories drive small cap risers in 2010
December 21, 2010
European companies hoping for a Christmas bonus
September 06, 2010
EP Vantage Interview - TiGenix seeking regenerative niche
Load More
Latest Reports
July 27, 2023
H1 Round Up: The haves and the have-nots
July 21, 2023
ADA/EASL eBook
Editor's Picks
July 03, 2023
Astrazeneca and Daiichi’s big reveal disappoints
July 13, 2023
Pharma finds a way to gain weight
July 03, 2023
Protagonist investors flake as psoriasis pill disappoints
June 29, 2023
Approaching datasets for big pharma
June 27, 2023
Nkarta goes back to basics